Association of SV40 with human tumours

Seminars in Cancer Biology

Volumn 11, Issue 1, 2001, Pages 49-61

  Jasani, B ^a   Cristaudo, A ^b   Emri, S A ^c   Gazdar, A F ^d   Gibbs, A ^a   Krynska, B ^e   Miller, C ^f   Mutti, L ^g   Radu, C ^a   Tognon, M ^h   Procopio, A ⁱ  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF PISA   (Italy)

^c HACETTEPE UNIVERSITY   (Turkey)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

^e DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Institute for Research and Care   (Italy)

^h UNIVERSITY OF FERRARA   (Italy)

ⁱ UNIVERSITY OF CHIETI   (Italy)

Author keywords

Cancer; Human tumour; PCR; SV40

Indexed keywords

POLIOMYELITIS VACCINE; VIRUS DNA;

ARTICLE; DISEASE ASSOCIATION; EPENDYMOMA; HUMAN; MESOTHELIOMA; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40; TUMOR; VIRUS CARCINOGENESIS;

EID: 0035106013     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.2000.0346     Document Type: Article

References (107)

1. The vacuolating virus S.V.40
2. Development of tumours in hamsters inoculated in the neonatal period with vacuolating virus, SV40
3. BK and JC human polyomaviruses and simian virus 40: Natural history of infection in humans, experimental oncogenicity and association with human tumours
4. Transformation induced by simian virus 40 in human renal cell cultures. I. Morphology and growth characteristics
5. Patterns of antibodies to SV40 in children following the last booster with inactivated poliomyelitis vaccines
6. SV40-induced immortalisation of human cells
7. Search for SV40 in human mesotheliomas in human mesothelioma
8. Cell and molecular biology of simian virus 40: Implications for human infections and disease
9. Persistent infection of human carcinoma and primary chick embryo cell cultures with simian virus 40
10. Excretion of vacuolating SV40 virus (papova group) after ingestion as a contaminant of oral poliovaccine
11. Long-term follow-up of persons inadvertantly inoculated with SV40 as neonates
12. SV40 and human brain tumours
13. Simian virus 40, poliovaccines and human tumours: A review of recent developments
14. DNA sequences similar to those of simian virus 40 in ependymoas and choroid plexus tumours of childhood
15. Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumours
16. Simian virus 40-like DNA sequences in human pleural mesothelioma
17. SV40-like sequences in human bone tumours
18. Simian virus 40 large T antigen (SV0LTag) primer specific DNA amplification in human pleural mesothelioma tissue
19. Molecular biology studies on mesothelioma tumour samples: Preliminary data on H-ras, p21, and SV40
20. SV40 early region and large T antigen in human brain tumours, peripheral blood cells, and sperm fluids from healthy individuals
21. A broad spectrum PCR method for detection of polyomaviruses and avoidance of contamination by cloning vectors
22. Potential exposure to SV40 in polio vaccines used in Sweden during 1957: No impact on cancer incidence rates 1960 to 1993
23. Exposure to SV40-contaminated poliovirus vaccine and the risk of cancer - A review of the epidemiological evidence
24. SV40 as a putative human commensal
25. SV40 as an oncogenic virus and possible human pathogen
26. Simian virus-40 large T-antigen binds p53 in human mesotheliomas
27. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas
28. SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes
29. Sequence analyses of human tumour-associated SV40 DNAs and SV40 viral isolates from monkeys and humans
30. Human mesotheliomas contain the simian virus-40 regulatory region and large tumour antigen DNA sequences
31. Simian virus 40-like DNA sequences in human papillary thyroid carcinomas
32. Integration of SV40 in human osteosarcoma DNA
33. SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma, and non-malignant pulmonary diseases
34. SV40 expression in human neoplastic and non-neoplastic tissues: Perspectives on diagnosis, prognosis and therapy of human malignant mesothelioma in human mesothelioma
35. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas
36. Detection of SV40 sequences in human mesothelioma
37. Simian virus 40 (SV40)-like DNA sequences not detectable in Finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines
38. Simian virus 40 is present in most United States human mesotheliomas but it rarely present in non-Hodgkin's lymphoma
39. Identification in human brain tumours of DNA sequences specific for SV40 large T antigen
40. SV40 large T-antigen and human pleural mesothelioma - Screening by polymerase chain reaction and tyramine-amplified immunohistochemistry
41. Mutations of p53 gene and SV40 sequences in asbestos associated and nonasbestos-associated mesotheliomas
42. Expression of the simian virus 40 large tumour antigen (Tag) and formation of Tag-p53 and Tag-pRb complexes in human brain tumours
43. Anti-sense to early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells
44. Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations
45. Presence of simian virus 40 sequences in malignant pleural, peritoneal and nonivasive mesotheliomas
46. Presence and expression of the simian virus-40 genome in human giant cell tumours of bone
47. SV40, JC and BK expression in tissue, urine and blood samples from patients with malignant and non-malignant pleural disease
48. SV40 can be reproducibly detected in paraffin-embedded mesothelioma samples
49. Molecular characterisation of SV40 DNA in multiple samples from a human mesothelioma
50. High incidence of SV40-like sequences detection in tumour and peripheral blood cells of Japanese osteosarcoma patients
51. Simian virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant plenral mesothelioma in Turkey
52. Simian-virus-40 footprints in human lymphoproliferative disorders of HIV- and HIV+ patients
53. Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas
54. Simian virus-40 sequences are a negative prognostic co-factor in patients with malignant pleural mesothelioma
55. Adenovirus-mediated wild-type p53 overexpression reverts tumorigenicity of human mesothelioma cells
56. Molecular evidence of simian virus 40 infections in children
57. Simian virus 40 and human mesothelioma
58. Consideration of PCR methods for detection of SV40 in tissue and DNA specimens
59. The detection of simian virus 40 in human tumours by polymerase chain reaction
60. Simian virus 40 DNA detection in human mesotheliomas: Reliability and significance of the available molecular evidence
61. Cancer risk associated with simian virus 40 contaminated polio vaccine
62. Simian virus 40 and pleural mesothelioma in humans
63. Simian virus 40 and human pleural mesothelioma
64. Simian virus 40 in a human cancer
65. Simian virus 40-related antigens in three human meningiomas with defined chromosome loss
66. Studies of human papovavirus tumour antigen in experimental and human cerebral neoplasms
67. New molecular and epidemiological issues in mesotheliomas; role for SV40
68. Detection of large T-antigen (Tag) specific DNA in concurrent human prostatic and blood samples
69. Screening of human brain tumours for SV40-related T antigen
70. Simian virus-related DNA sequences in a human brain tumour
71. Isolation of SV40-like papovavirus from a human glioblastoma
72. Persistent BK papovavirus infection of transformed human fetal brain cells
73. Episomal simian virus 40 genomes in human brain tumours
74. Papovavirus-related RNA sequences in human neurogenic tumours
75. Cloning of SV40 genomes from human brain tumours
76. Investigations on the presence of papovavirus in certain forms of human cancer
77. Epithelial HBL-100 cell line derived from milk of an apparently healthy woman harbours SV40 genetic information
78. Issues related to the detection of SV40 DNA in human tissues
79. Large T antigen coding sequences of two DNA tumour viruses, BK and SV40 and nonrandom chromosome changes in glioblastoma cell lines
80. Introduction to Simian virus 40: Getting by with more than a little help from its host cell
81. Mutation of p53 is not a pre-requisite for immortalisation of human fibroblasts
82. p53 mutations are not selected for simian virus 40 T-antigen-induced tumours from transgenic mice
83. Differential ability of a T-antigen transport-defective mutant of simian virus 40 to transform primary and established rodent cells
84. Tumorigenesis in transgenic mice by a nuclear transport-defective SV40 large T-antigen gene
85. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen
86. SV40 rodent tumour models as paradigms of human disease: Transgenic mouse models
87. Lack of expression of the retinoblastoma gene is not frequently involved in the genesis of human mesothelioma
88. Absence of p53 mutations in malignant mesotheliomas
89. Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesothelioma
90. Molecular biology of mesothelioma
91. The environment and disease: Association or causation
92. Evidence of SV40 infections in hospitalised children
93. Simian virus 40 oncogenesis in hamsters
94. Induction of tumours in adult hamsters with simian virus 40
95. Oncogenesis and poliomyelitis vaccine
96. Immunisation during pregnancy against poliomyelitis and influenza in relation to childhood malignancy
97. Effect of SV40 virus contaminated polio vaccine on the incidence and type of CNS neoplasms in children: A population-based study
98. Medulloblastoma in childhood: An epidemiological study
99. Induction of tumour antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen
100. Simian virus 40-like DNA sequences and large-T antigen-etinoblastoma family protein pRb2/p130 interaction in human mesothelioma
101. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity
102. Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in paediatric medulloblastomas
103. Detection of SV40 like viral DNA and viral antigens in malignant pleural mesothelioma
104. Maintenance of episomal SV40 genome in GM637 human fibroblasts
105. Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumours
106. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates